肝胆相照论坛

标题: 肝硬化患者的多药耐药细菌感染:流行病学研究 [打印本页]

作者: StephenW    时间: 2018-8-29 08:28     标题: 肝硬化患者的多药耐药细菌感染:流行病学研究

Original Research
Multidrug-resistant bacterial infections in cirrhotic patients: an epidemiological study
Ruihong Zhao, Jianke Ma, Pengcheng Li, Hong Fang, Shanshan Sun, Wei Wu, show all
Received 13 Jun 2018, Accepted 21 Aug 2018, Accepted author version posted online: 28 Aug 2018

    Download citation https://doi.org/10.1080/17474124.2018.1515627

Accepted author version
Abstract

Background: The purpose of this study is to describe the epidemiological features of bacterial infections caused by MDR bacteria in cirrhotic patients and their impact on mortality.

Methods: A retrospective study of cirrhotic patients with culture-confirmed bacterial infections was performed between 2011 and 2017.

Results: A total of 635 episodes in 563 patients with cirrhosis were included. Bacterial infections caused by MDR isolates accounted for 44.1% (280/635) of the episodes, nearly half of which were hospital acquired (48.4%). The most common MDR isolation site was the respiratory tract (36.4%, 102 episodes), followed by the abdominal cavity (35.4%, 99 episodes). Of the MDR isolates, carbapenem-resistant Enterobacteriaceae (CRE) (91 episodes) were the most common. Patients infected with MDR bacteria had significantly higher mortality than those not infected (25.1% vs 17.4%, p=0.025). However, this increased mortality could be largely attributed to MRSA. After adjustment for age, sex and the MELD score, only MRSA infection was an independent risk factor for 28-day mortality in the multivariable Cox proportional hazard regression model analysis (HR, 2.964, 95% CI (1.175-7.478), p=0.021).

Conclusions: MDR bacterial infections, especially CRE, have become frequent in patients with cirrhosis in recent years, with MRSA infections significantly increasing short-term mortality.
Keywords: Bacterial infections, liver cirrhosis, multidrug-resistant bacteria, mortality, prognosis
作者: StephenW    时间: 2018-8-29 08:28

原创研究
肝硬化患者的多药耐药细菌感染:流行病学研究
赵瑞红,马建科,李鹏程,洪芳,孙珊珊,吴伟,全部展示
收稿日期2018年6月13日,接受2018年8月21日,接受作者发布于2018年8月28日

    下载引文https://doi.org/10.1080/17474124.2018.1515627

接受的作者版本
抽象

背景:本研究的目的是描述肝硬化患者MDR细菌引起的细菌感染的流行病学特征及其对死亡率的影响。

方法:对2011年至2017年间培养证实的细菌感染的肝硬化患者进行回顾性研究。

结果:共纳入563例肝硬化患者的635次发作。由MDR分离株引起的细菌感染占发作的44.1%(280/635),其中近一半是医院获得的(48.4%)。最常见的MDR分离部位是呼吸道(36.4%,102集),其次是腹腔(35.4%,99集)。在MDR分离株中,碳青霉烯抗性肠杆菌科(CRE)(91集)是最常见的。感染MDR细菌的患者死亡率显着高于未感染的患者(25.1%vs 17.4%,p = 0.025)。然而,死亡率上升可能主要归因于MRSA。在调整年龄,性别和MELD评分后,在多变量Cox比例风险回归模型分析中,仅MRSA感染是28天死亡率的独立危险因素(HR,2.964,95%CI(1.175-7.478),p = 0.021 )。

结论:MDR细菌感染,特别是CRE,近年来在肝硬化患者中频繁发生,MRSA感染显着增加短期死亡率。
关键词:细菌感染,肝硬化,多药耐药细菌,死亡率,预后




欢迎光临 肝胆相照论坛 (http://hbvhbv.info/forum/) Powered by Discuz! X1.5